Search

Abstracts

  1. Menefee S. A Randomized Trial of Sacral Colpopexy, Transvaginal Mesh, and Native Tissue Apical Repair for Post-hysterectomy Vault Prolapse. SGS, Tuscon, Arizona, March 19-22, 2023. Accepted as Oral Presentation Submitted 3/1/2023. President's Award - 2023 Prize Paper for Outstanding Research in Gynecologic Surgery
  2. Lukacz E. Characteristics associated with successful treatment of accidental bowel leakage (ABL) in women enrolled in a randomized sham-controlled trial of Percutaneous Tibial Nerve Stimulation (PTNS). AUGS/IUGA, Austin, Texas, June 14-18, 2022. Accepted as Poster
  3. Bowen S. Pelvic Floor Muscle Shape is Associated with Anatomic Recurrence After Apical Prolapse Repair. AUGS/IUGA, Austin, Texas, June 14-18, 2022. Accepted as Oral Presentation
  4. Meyer I. Correlation Between Mobile-Application Electronic Bowel Diary and Validated Questionnaires in Women with Fecal Incontinence. AUGS/IUGA, Austin, Texas, June 14-18, 2022. Accepted as Poster
  5. Lukacz E. NOTABLe Predictors of response in PTNS group. AUGS/IUGA, Austin, Texas, June 14-18, 2022. Accepted as Poster
  6. Zyczynski H. 6-month Effects of Percutaneous Tibial Nerve Stimulation Compared to Sham Treatment for Refractory Fecal Incontinence . AUGS/IUGA, Austin, Texas, June 14-18, 2022. Accepted as Poster
  7. Napoe GS. Clinical and Procedure Characteristics of Women Electing Surgical Management for Recurrent Prolapse After Sacrospinous Hysteropexy with Mesh Graft. SGS, San Antonio Hill Country, Texas, March 27-30, 2022. Accepted as Poster
  8. Jelovsek E, Sung V. Development and validation of models to predict persistent stress and urgency urinary incontinence and need for additional treatment in women planning midurethral sling for mixed urinary incontinence. ICS, Virtual, October 14-17, 2021. Accepted as Oral Presentation
  9. Florian-Rodriguez M. Association of placebo response genetic polymorphisms and outcomes following percutaneous tibial nerve stimulation or sham in women with fecal incontinence (NOTABLe Placebome). ICS, Virtual, October 14-17, 2021. Accepted as Oral Presentation
  10. Florian-Rodriguez M. Association of placebo response genetic polymorphisms and outcomes following percutaneous tibial nerve stimulation or sham in women with fecal incontinence (NOTABLe Placebome). AUGS PFD Week, Phoenix, Arizona, October 12-15, 2021. Accepted as Oral Presentation Best Basic Science Paper
  11. Bradley M. Should a Wide Pre-operative GH Be Addressed During Native Tissue Prolapse Repair: A secondary analysis of the OPTIMAL and SUPeR trials. AUGS PFD Week, Phoenix, Arizona, October 12-15, 2021. Accepted as Oral Presentation
  12. Giugale L. Urinary outcomes through 5 years after transvaginal uterine prolapse repair with and without concomitant midurethral slings (SUPeR SUI). AUGS PFD Week, Phoenix, Arizona, October 12-15, 2021. Accepted as Oral Presentation
  13. Bowen S. A Quantitative Analysis of Differences in Vaginal Shape and Position on MRI After Vaginal Hysterectomy with Uterosacral Ligament Suspension vs Transvaginal Mesh Hysteropexy. AUGS PFD Week, Phoenix, Arizona, October 12-15, 2021. Accepted as Oral Presentation
  14. Richter H. Risk Factors Associated with Surgical Failure Over 5 Years in a Randomized Trial of Sacrospinous Hysteropexy With Graft vs Vaginal Hysterectomy with Uterosacral Ligament Suspension for Uterovaginal Prolapse. AUGS PFD Week, Phoenix, Arizona, October 12-15, 2021. Accepted as Oral Presentation Best Clinical Paper
  15. Sung V, Jelovsek E. Development and validation of models to predict persistent stress and urgency urinary incontinence and need for additional treatment in women planning midurethral sling for mixed urinary incontinence. AUGS PFD Week, Phoenix, Arizona, October 12-15, 2021. Accepted as Oral Presentation
  16. Bowen S, Moalli P, Abramowitch SD, Lockhart ME, Weidner A, Ferrando CA, Richter H, Rardin C, Komesu Y, Harvie H, Nager C, Mazloomdoost D, Sridhar A, Gantz M. Vaginal Angulation after Vaginal Hysterectomy with Uterosacral Ligament Suspension or Vaginal Mesh Hysteropexy: Investigating the Role of Vaginal Configuration in Anatomic Failure of Apical Prolapse Repair. AUGS, Virtual, October 08-10, 2020. Accepted as Oral Presentation Best Basic Science Award
  17. Richter HE. Microbiome Predictors of Surgical Treatment Response in Women Undergoing Mid-urethral Sling Surgery for Mixed Urinary Incontinence . AUGS Annual Scientific Meeting, Virtual, October 06-10, 2020. Accepted as Oral Presentation
  18. Zyczynski H. A Randomized Trial Comparing Neuromodulation with Percutaneous Tibial Nerve Stimulation to Sham Treatment for Accidental Bowel Leakage – The NOTABLe Trial. AUGS Annual Scientific Meeting, Virtual, October 06-10, 2020. Accepted as Oral Presentation
  19. Eric Jelovsek J. Success and failure are dynamic, recurrent event states that alternate after surgical treatment for pelvic organ prolapse. : IUGA 45th Annual Conference, Virtual, August 29 - September 04, 2020. Accepted as Oral Presentation Best Abstract Award
  20. Richter HE. Microbiome Predictors of Surgical Treatment Response in Women Undergoing Mid-urethral Sling Surgery for Mixed Urinary Incontinence. International Continence Society, Virtual, August 26-29, 2020. Accepted as Oral Presentation Best Presentation Award
  21. Rogers R. Body Image and Sexual Function. SGS, Jacksonville, Florida, July 06-09, 2020. Accepted as Poster
  22. Zyczynski H, Richter HE, Sung VW, Arya L, Lukacz E, Visco A, Rahn DD, Carper B, Mazloomdoost D, Gantz M. Study of performance, acceptability and validation of the PFDN phone application electronic bowel diary (eDiary). Society of Gynecologic Surgeons, Jacksonville, Florida, July 06-09, 2020. Accepted as Oral Presentation View
  23. Bowen S. Outcomes of the defining mechanisms of anterior vaginal wall descent trial. Society of Gynecologic Surgeons, Jacksonville, Florida, July 06-09, 2020, Jacksonville, Florida, July 06-09, 2020. Accepted as Oral Presentation Best Manuscript Award
  24. Jelovsek E, Amundsen CL, Thomas S, Smith A, Komesu Y, Gill B, Barden L. Intraoperative and Perioperative Predictors for InterStim Implantation and Efficacy. AUA, Washington, DC, May 15-18, 2020. Accepted as Oral Presentation Conference cancelled due to COVID-19
  25. Erekson E. 30-Day Complications. American Geriatrics Society, Long Beach, CA, May 06-09, 2020. Accepted as Oral Presentation Conference cancelled due to COVID-19
  26. Swankie T. – Source Documentation: Common Pitfalls and Site Monitoring Visit Findings. SOCRA, San Antonio. Tx, September 27-29, 2019. Accepted as Oral Presentation
  27. Sung VW, Richter HE, Weidner AC, Moalli P, Nguyen JN, Smith A, Newman DK, Borello-France D, Dunivan G, Ridgeway B, Mazloomdoost D, Carper B, Gantz M. Characteristics associated with treatment failure 1 year after midurethral sling in women with mixed urinary incontinence. Joint meeting American Urogynecologic Society and International Urogynecological Association, Nashville, TN, September 24-28, 2019. Accepted as Oral Presentation
  28. Markland A. Anal Manometry Validity. AUGS/IUGA, Nashville, TN, September 24-28, 2019. Accepted as Oral Presentation
  29. Andy UU, Amundsen C, Honeycutt E, Markland A, Dunivan G, Dyer K, Korbly NB, Bradley M, Vasavada S, Mazloomdoost D, Thomas S. Impact of Refractory Urgency Urinary Incontinence treatment on bowel and sexual function. SGS, Tucson, AZ, March 31 - April 03, 2019. Accepted as Poster
  30. Sutkin G. Posterior Repair Does Not Affect the Success of Transvaginal Repair of Apical Prolapse. SGS, Tucson, AZ, March 31 - April 03, 2019. Accepted as Oral Presentation
  31. Barber M. Pain and activity after vaginal reconstructive surgery for pelvic organ prolapse. SGS, Tucson, AZ, March 31 - April 03, 2019. Accepted as Oral Poster
  32. Andy UU. Impact of treatment for Fecal Incontinence on Defecatory Symptoms . American Urogynecologic Society, Chicago, Illinois, October 09-13, 2018. Accepted as Oral Presentation
  33. Brubaker L. Randomized Study of Video-Enhanced vs. Usual Research Consent Process for the E-OPTIMAL Study . American Urogynecologic Society, Chicago, Illinois, October 09-13, 2018. Accepted as Oral Presentation
  34. Harvie H. Cost-Effectiveness of Sacral Neuromodulation vs. Botox for Refractory Urgency Urinary Incontinence: Results from the ROSETTA Trial . American Urogynecologic Society, Chicago, Illinois, October 09-13, 2018. Accepted as Oral Presentation
  35. Nager C. Vaginal Surgery for Uterovaginal Prolapse: A Randomized Trial of Vaginal Hysterectomy With Native Tissue Vault Suspension Versus Mesh Hysteropexy. American Urogynecologic Society, Chicago, Illinois, October 09-13, 2018. Accepted as Oral Presentation
  36. Rogers R. The responsiveness and minimally important difference of a new measure of fecal incontinence severity; The Accidental Bowel Leakage Evaluation Questionnaire (ABLE) . American Urogynecologic Society, Chicago, Illinois, October 09-13, 2018. Accepted as Oral Presentation
  37. Sung V, Newman DK, Borello-France D, Richter HE, Lukacz E, Moalli P, Weidner A, Smith AL, Dunivan G, Ridgeway B, Mazloomdoost D, Carper B, Gantz M. A Randomized Trial Comparing Combined Midurethral Sling and Behavioral/Pelvic Floor Therapy to Midurethral Sling Alone for Mixed Urinary Incontinence – The ESTEEM Trial . American Urogynecologic Society, Chicago, Illinois, October 09-13, 2018. Accepted as Oral Presentation Best Clinical Paper Award
  38. Komesu Y. How related are the urinary and vaginal microbiomes . American Urogynecologic Society, Chicago, Illinois, October 09-13, 2018. Accepted as Oral Poster
  39. Richter HE. Characteristics Associated With A Clinically Important Treatment Response in Women Under-going Non-surgical Therapy for Fecal Incontinence . American Urogynecologic Society, Chicago, Illinois, October 09-13, 2018. Accepted as Oral Presentation
  40. Richter HE. Patient Characteristics Associated With A Clinically Important Treatment Response in Women Under-going Non-surgical Therapy for Fecal Incontinence . International Continence Society, Philadelphia, Pennsylvania, August 28-31, 2018. Accepted as Oral Presentation
  41. Sung VW, Newman DK, Borello-France D, Richter HE, Lukacz E, Weidner A, Smith AL, Dunivan G, Ridgeway B, Mazloomdoost D, Carper B, Gantz M. A Randomized Trial Comparing Combined Midurethral Sling and Behavioral/Pelvic Floor Therapy to Midurethral Sling Alone for Mixed Urinary Incontinence – The ESTEEM Trial . International Continence Society, Philadelphia, Pennsylvania, August 28-31, 2018. Accepted as Oral Presentation Best Conservative Management Award
  42. Thomas S, Swankie T. – CONDUCTING HIGH-IMPACT, HIGH-QUALITY CLINICAL TRIALS: SITE STAFF TRAINING AS A COMPONENT OF QUALITY. Society for Clinical Trials, , May 21-23, 2018. Accepted as Oral Presentation
  43. Jelovsek JE, Markland AD, Whitehead WE, Barber MD, Newman DK, Rogers RG, Dyer K, Visco A, Sung VW, Sutkin G, Meikle SF, Gantz MG, Carper B. Controlling anal incontinence in women by performing anal exercises with biofeedback or loperamide: THe CAPABLe Trial. American Urogynecologic Society, Providence, RI, October 03-07, 2017. Accepted as Oral Presentation Best Abstract at AUGS PFD week 2017
  44. Dunivan G. The Patient Perspective on Pelvic Floor Disorders Surgical Adverse Events. American Urogynecologic Society, Providence, RI, October 03-07, 2017. Accepted as Oral Poster
  45. Harvie H. Responsiveness and Minimally Important Difference of SF-6D and EQ-5D Utility Scores for the Treatment of Pelvic Organ Prolapse. American Urogynecologic Society, Providence, RI, October 03-07, 2017. Accepted as Oral Poster
  46. Komesu Y. The Urinary Microbiome in Women With Mixed Urinary Incontinence. American Urogynecologic Society, Providence, RI, October 03-07, 2017. Accepted as Oral Poster
  47. Rogers RG, Bann CM, Sung VW, Lukacz ES, Fairchild P, Arya L, Barber MD, Markland A, Siddiqui NY, Pelvic Floor Disorders Network. Accidental Bowel Leakage Evaluation (ABLE): A New Patient-Centered Validated Measure of Accidental Bowel Leakage Symptoms. American Urogynecologic Society, Providence, RI, October 03-07, 2017. Accepted as Oral Poster
  48. Amundsen CL, Wilson TS, Wallace D, Vasavada S, Nguyen JN, Myers DL, Komesu YM, Harvie HS, Gregory WT, Chermansky C, Honeycutt EF. Two-Year Outcomes of Sacral Neuromodulations vs. Onabotulinumtoxina for Refractory Urgency Urinary Incontinence. American Urogynecologic Society, Providence, RI, October 03-07, 2017. Accepted as Oral Presentation Best Overall Paper at AUGS PFD week 2017  View
  49. Chermansky C, Wilson TS, Wallace D, Vasavada S, Nguyen JN, Myers D, Komesu Y, Honeycutt EF, Harvie H, Gregory WT, Amundsen C. Two-Year Outcomes of Sacral Neuromodulation Versus Onabotulinumtoxina for Refractory URgency Urinary Incontinence. ICS, Florence, Italy, September 12-15, 2017. Accepted as Oral Presentation
  50. Jelovsek JE. Five-Year Outcomes of Uterosacral Ligament Suspension or Sacrospinous Ligament Fixation for Apical Pelvic Organ Prolapse: A Randomized Trial. IUGA, Vancouver, Canada, June 20-24, 2017. Accepted as Oral Presentation Prize Paper at SGS 2017
  51. Richter HE, Amundsen C, Jelovsek E, Erickson S, Komesu Y, Chermansky C, Kadima N, Myers D, Harvie H, Albo M, Wallace D. Demographic and clinical variables associated with treatment response in women undergoing OnabotulinumtoxinA and sacral neuromodulation. American Urologic Association, Boston, MA, May 12-16, 2017. Accepted as Oral Presentation.
  52. Jelovsek JE. A Randomized Trial of Uterosacral Ligament Suspension or Sacrospinous Ligament Fixation for Apical Pelvic Organ Prolapse: Five-year Outcomes. Society of Gynecologic Surgeons, San Antonio, TX, March 26-29, 2017. Accepted as Oral Presentation Axel Ingelman-Sundberg Best Paper Award
  53. Amundsen C, Richter H, Menefee S, Komesu Y, Arya L, Gregory WT, Myers D, Zyczynski H, Vasavada S, Nolen T, Wallace D, Meikle S. The Refractory Overactive Bladder: Sacral Neuromodulation versus OnabotulinumtoxinA for Refractory Overactive Bladder. International Incontinence Society, Tokyo, Japan, September 13-16, 2016. Accepted as Oral Presentation
  54. Richter HE, Moalli P, Amundsen C, Malykhina AP, Rogers R, Myers D, Paraiso M, Albo M, Nolen T, Wallace D, Meikle S, Word RA. The ROSETTA Urinary Marker Study. Open Discussion. International Incontinence Society, Tokyo, Japan, September 13-16, 2016. Accepted as Poster
  55. Richter HE, Moalli P, Amundsen C, Malykhina AP, Rogers R, Myers D, Paraiso M, Albo M, Shi H, Nolen T, Wallace D, Meikle S, Word RA. The ROSETTA Urinary Marker Study. American Urologic Society, San Diego, CA, May 06-10, 2016. Accepted as Poster
  56. Amundsen C. Sacral Neuromodulation versus OnabotulinumtoxinA for Refractory Overactive Bladder. American Urologic Society, San Diego, CA, May 06-10, 2016. Accepted as Oral Presentation
  57. Lukacz ES, Warren LK, Richter HE, Brubaker L, Barber MD, Norton P, Weidner A, Nguyen JN, Gantz MG, Meikle SF. Long-term quality of life and sexual function after vaginal surgery for apical prolapse: analysis of a randomized trial of uterosacral and sacrospinous suspensions. American Urogynecologic Society, Seattle, WA, October 13-17, 2015. Accepted as Oral Poster
  58. Lukacz ES, Warren LK, Richter HE, Brubaker L, Barber MD, Norton P, Weidner A, Nguyen JN, Gantz MG, Meikle SF. Long-term quality of life and sexual function after vaginal surgery for apical prolapse. International Urogynecological Association, Nice, France, June 09-13, 2015. Accepted as Oral Presentation
  59. Weidner A, Barber M, Markland A, Rahn D, Hsu Y, Mueller ER, Jakus-Waldman S, Dyer KY, Warren LK, Gantz MG, Meikle S. Perioperative Behavioral Therapy & Pelvic Muscle Strengthening Does Not Improve Quality of Life After Apical Prolapse Surgery: A Randomized, Controlled Trial . International Urogynecological Association, Nice, France, June 09-13, 2015. Accepted as Oral Presentation View
  60. Wilson K, Ham M, Moalli P, Lockhart ME, Abramowitch SD, Wallace D. The Use of Open-Source Wed-Based Tools to Facilitate and Support an MRI Imaging Study of Anterior Vaginal Wall Descent in Women With Pelvic Organ Prolapse. Society for Clinical Trials, Arlington, VA, May 17-20, 2015. Accepted as Oral Presentation Submitted 2/17/2015. View
  61. Rogers RG, Weidner A, Richter HE, Nolen T, Jelovsek JE, Shepherd JP, Myers D, Menefee S, Brubaker L, Hsu Y, Schaffer J, Wallace D, Meikle S, Harvie H. Sacrocolpopexy (ASC) and vaginal native tissue apical repair (VAR): A retrospective comparison of success and serious adverse events (SAE) among randomized trial participants. Society of Gynecologic Surgeons, 41st Annual Meeting, Orlando, FL, March 21-25, 2015. Accepted as Oral Poster
  62. Brubaker L, Wolfe AJ, Pearce MM, Zilliox MJ, Rosenfeld AB, Thomas-White KJ, Richter HE, Nager CW, Visco AG, Nygaard I, Barber MD, Schaffer J, Moalli P, Sung VW, Smith AL, Rogers R, Nolen T, Wallace D, Meikle SF, Gai X, Wolfe AJ. The Urinary Microbiome of Women with Urinary Urgency Incontinence. International Continence Society, Rio de Janiero, Brazil, October 20-24, 2014. Accepted as Poster
  63. Rogers RG, Nolen T, Jelovsek JE, Richter HE, Weidner A, Harvie H, Myers D, Menefee S, Brubaker L, Hsu Y, Schaffer J, Shepherd JP, Wallace D, Meikle S. Post-hysterectomy patients are as likely as patients with uterovaginal prolapse to have successful prolapse surgery. American Urogynecologic Society/International Urogynecological Association Annual Meeting, Washington, DC, July 21-26, 2014. Accepted as Oral Poster
  64. Richter HE, Whitehead N, Allen-Brady K, Norton P, Arya L, Page GP, Gaddis N, Ridgeway B, Sung V, Komesu Y, Shepherd JP, Fraser MO, Tan-Kim J, Meikle S. Urgency Urinary Incontinence Genome Wide Association Study. American Urogynecologic Society/International Urogynecological Association Annual Meeting, Washington, DC, July 21-26, 2014. Accepted as Oral Presentation
  65. Whitehead N, Richter HE, Allen-Brady K, Arya L, Sung V, Norton P, Ridgeway B, Komesu Y, Shepherd JP, Page GP, Fraser MO, Tan-Kim J, Gaddis N, Meikle S. Genome Wide Association Study of Urgency Urinary Incontinence. Society for Epidemiology Research, Seattle, WA, June 24-27, 2014. Accepted as Poster
  66. Sung V, Rogers RG, Bann C, Arya LA, Barber MD, Lowder JL, Lukacz ES, Markland A, Siddiqui NY, Wilmot A, Meikle S, Pelvic Floor Disorders Network. Conceptual Framework for Anal Incontinence Symptom Outcomes in Women. American Urogynecologic Society, Las Vegas, NV, October 17-19, 2013. Accepted as Oral Presentation View
  67. Visco A. Adherence to Randomized Therapy for Urgency Urinary Incontinence: Results from the ABC (Anticholinergic vs Botox Comparison) Trial . American Urogynecologic Society, Las Vegas, NV, October 16-19, 2013. Accepted as Poster View
  68. Jelovsek JE. A new model for predicting the risk of postoperative stress urinary incontinence in women without stress incontinence symptoms undergoing pelvic organ prolapse surgery. American Urogynecologic Society, Las Vegas, NV, October 16-19, 2013. Accepted as Oral Presentation
  69. Richter HE, Nager CW, Whitworth R, Burgio K, Schaffer J, Norton P, Weidner A, Jelovsek JE, Zyczynski H, Meikle S, Spino C, Gantz M, Graziano S, Brubaker L. Incidence and Predictors of Anal Incontinence after Obstetric Anal Sphincter Injury in Primiparous Women. American Urogynecologic Society, Las Vegas, NV, October 16-19, 2013. Accepted as Poster
  70. Jelovsek JE. A model for predicting the risk of de novo stress urinary incontinence in women undergoing pelvic organ prolapse surgery. International Continence Society, Barcelona, Spain, August 26-31, 2013. Accepted as Oral Presentation
  71. Richter HE, Nager CW, Whitworth R, Burgio K, Schaffer J, Norton P, Weidner A, Jelovsek JE, Zyczynski H, Meikle S, Spino C, Gantz M, Graziano S, Brubaker L. Incidence and Correlates of Anal Incontinence after Obstetric Anal Sphincter Injury in Primiparous Women. International Continence Society, Barcelona, Spain, August 26-31, 2013. Accepted as Poster
  72. Mueller ER, Corton M. Multi-Center Multispecialty Certification for Ultrasound of Anal Sphincter Anatomy. Society of Gynecologic Surgeons, Charleston, SC, April 08-10, 2013. Accepted as Poster
  73. Brubaker L, Visco AC, Wolfe AJ, Richter HE, Nager C, Nygaard I, Barber M, Schaffer J, Wallace D, Meikle S. The Urinary Microbiome in Participants with Urgency Urinary Incontinence Randomized to Anticholinergic versus Botulinum Toxin in the ABC Trial. American Urogynecologic Society, Chicago, IL, October 03-06, 2012. Accepted as Oral Presentation
  74. Visco AG, Brubaker L, Richter HE, Nygaard I, Paraiso MF, Menefee SA, Schaffer J, Lowder J, Khandwala S, Sirls L, Spino C, Wallace D, Meikle S. Anticholinergic versus Botulinum Toxin-A Comparison Trial for the Treatment of Urgency Urinary Incontinence: The ABC Randomized Trial. 2012 American Urogynecologic Society, Chicago, IL, October 03-06, 2012. Accepted as Oral Presentation
  75. Gutman RE, Nygaard I, Richter HE, Ye W. The Pelvic Floor Complications Scale: A New Instrument to Measure Complications Associated with Reconstructive Pelvic Surgery. American Urogynecologic Society 32nd Annual Meeting, Providence, RI, September 14-17, 2011. Accepted as Oral Presentation
  76. Wei JT, Nygaard I, Richter HE, Spino C, Kenton K, Barber MD, Nager C, Amundsen C, Janz N, Schaffer J, Meikle S. A Mid Urethral Sling Prevents Incontinence among Women undergoing Vaginal Prolapse Repair – The OPUS Trial. 41st Annual Meeting International Continence Society, Glaskow, UK, August 29 - September 02, 2011. Accepted as Oral Presentation
  77. Markland AD, Wang L, Jelovsek JE, Brubaker L, Tuteja A, Wei JT, Weidner AC, LoSavio A, Meikle S, Corton M, Richter HE. Long-Term Symptom Improvement in Women with Fecal Incontinence: A Multicenter Cohort Study of the Pelvic Floor Disorders Network. 2011 Digestive Disease Week, Chicago, IL, May 07-10, 2011. Accepted as Poster
  78. Markland A. Long Term Symptom Improvement in Women with Fecal Incontinence after Surgical and Non-Surgical Treatments: A Multicenter Cohort Study of the Pelvic Floor Disorders Network. Digestive Disease Week , Chicago, IL, May 07-10, 2011. Accepted as Oral Presentation View
  79. Barber M. Validation of the activities assessment scale in women undergoing pelvic reconstructive surgery. Society of Gynecologic Surgeons, San Antonio, TX, April 11-13, 2011. Accepted as Oral Presentation View
  80. Barber M. Validation of the surgical pain scales in women undergoing pelvic reconstructive surgery. Society of Gynecologic Surgeons, San Antonio, TX, April 11-13, 2011. Accepted as Poster View
  81. Handa V. Sexual Function Before and After Non-surgical Treatment for Stress Urinary Incontinence. American Urogynecologic Society, Long Beach, CA, September 30 - October 02, 2010. Accepted as Oral Presentation View
  82. Kenton K. Overall Pelvic Floor Symptoms Improve Similarly After Pessary and Behavioral Treatment for Stress Incontinence. American Urogynecologic Society, Long Beach, CA, September 30 - October 02, 2010. Accepted as Oral Presentation View
  83. Markland A. Impact of Irritable Bowel Syndrome in Women with Fecal Incontinence. . American Urogynecologic Society, Long Beach, CA, September 30 - October 02, 2010. Accepted as Poster View
  84. Schaffer J. Predictors of Success and Satisfaction of Non-surgical Therapy for Stress Urinary Incontinence. American College of Obstetrics and Gynecology, San Francisco, CA, May 15-19, 2010. Accepted as Poster View
  85. Brubaker L. Quantification of vaginal support: Are continuous scores better than POP-Q stage?. Society of Gynecologic Surgeons, Tucson, AZ, April 12-14, 2010. Accepted as Oral Presentation View
  86. Wei J. Development and validation of an Adaptation Index for women with pelvic floor disorders (PFD). International Society for Quality of Life Research, New Orleans, LA, October 28-31, 2009. Accepted as Oral Presentation View
  87. Brubaker L. Defining “success” after surgery for pelvic organ prolapse. . Society of Pelvic Surgeons, Nashville, TN, October 21-24, 2009. Accepted as Oral Presentation View
  88. Barber M. Defining “success” after surgery for pelvic organ prolapse. International Continence Society, San Francisco, CA, September 29 - October 03, 2009. Accepted as Oral Presentation View
  89. Richter HE. A Randomized Trial of Pessary vs. Behavioral Therapy vs. Combined Therapy for Treatment of Stress Urinary Incontinence. International Continence Society, San Francisco, CA, September 29 - October 03, 2009. Accepted as Oral Presentation View
  90. Barber M. Further Validation of the Pelvic Floor Distress Inventory-20 (PFDI-20) and Pelvic Floor Impact Questionnaire-7 (PFIQ-7) short forms. American Urogynecologic Society, Hollywood, FL, September 24-26, 2009. Accepted as Oral Presentation View
  91. Nygaard I. Correlation between levator Ani Muscle Injury on MRI and Fecal Incontinence, Pelvic Organ Prolapse and Urinary Incontinence in Primparous Women. American Urogynecologic Society, Hollywood, FL, September 24-26, 2009. Accepted as Oral Presentation View
  92. Handa VL, Nygaard I, Kenton KS, Cundiff GW, Ghetti C, Ye W, Richter HE. Pelvic organ support among Primiparous women in the first year after childbirth. American Urogynecologic Society, Hollywood, FL, September 24-26, 2009. Accepted as Oral Presentation View
  93. Richter HE. A Randomized Trial of Pessary vs. Behavioral Therapy vs. Combined Therapy for Treatment of Stress Urinary Incontinence. American Urogynecologic Society, Hollywood, FL, September 24-26, 2009. Accepted as Oral Presentation View
  94. Bradley C.. The Questionnaire for Urinary Incontinence Diagnosis (QUID): Validity and responsiveness to change in women undergoing non-surgical therapies for treatment of stress predominant urinary incontinence. . AUA, Chicago, IL, April 25-30, 2009. Accepted as Poster View
  95. Barber M. Defining “success” after surgery for pelvic organ prolapse. AUA, Chicago, IL, April 25-30, 2009. Accepted as Oral Presentation View
  96. Gutman R. Effects of colpocleisis on bowel symptoms among women with severe pelvic organ prolapse. Society of Gynecologic Surgeons, New Orleans, LA, March 30 - April 01, 2009. Accepted as Oral Presentation View
  97. Barber M. Defining “success” after surgery for pelvic organ prolapse. Society of Gynecologic Surgeons, New Orleans, LA, March 30 - April 01, 2009. Accepted as Oral Presentation View
  98. Lockhart ME. Magnetic resonance assessment of pelvic anatomy and pelvic floor disorders symptoms after childbirth. Society of Uroradiologists, Maui, HI, March 15-20, 2009. Accepted as Oral Presentation View
  99. Fitzgerald MP. Pelvic support, pelvic symptoms and patient satisfaction after colpocleisis. International Continence Society, Cairo, Egypt, October 20-24, 2008. Accepted as Oral Presentation View
  100. Brubaker L. Risk Factors for Mesh/Suture Erosion Following Sacrocolpopexy. International Continence Society, Cairo, Egypt, October 20-24, 2008. Accepted as Oral Presentation View
  101. Barber MD. The Minimum Important Differences for the Urinary Scales of the Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire. AUGS, Chicago, IL, September 04-06, 2008. Accepted as Oral Presentation View
  102. Nager CW. POPQ Measures Do Not Predict Incontinence Pessary Size. AUGS, , September 04-06, 2008. Accepted as Oral Presentation View
  103. Goode P. Enhancing Participation of Older Women in Surgical Trials. ICI, Paris, France, July 05-08, 2008. Accepted as Oral Presentation View
  104. Brubaker L. Refractory Idiopathic Urge Urinary Incontinence and Botulinum A Injection. . ICI, Paris, France, July 05-08, 2008. Accepted as Oral Presentation View
  105. Brubaker L. Two-year Outcomes Following Sacrocolpopexy with and without Burch to Prevent Stress Urinary Incontinence. ICI, Paris, France, July 05-08, 2008. Accepted as Oral Presentation View
  106. Mueller E. Does Urethral Function Affect Urodynamic Voiding Parameters in Women with Prolapse? . ICI, Paris, France, July 05-08, 2008. Accepted as Oral Presentation View
  107. The correlations of voiding variables between non-instrumented uroflowmetery and pressure-flow studies in women with pelvic organ prolapse. ICI, , July 05-08, 2008. Accepted as Oral Presentation View
  108. Richter HE. Ultrasound and magnetic resonance imaging of the anal sphincter after first delivery: Relationship to fecal incontinence symptoms. ICI, Paris, France, July 05-08, 2008. Accepted as Oral Presentation View
  109. Richter HE. Non-Surgical Management of Stress Urinary Incontinence: Ambulatory Treatments for Leakage Associated with Stress Incontinence (ATLAS) Trial. ICI, Paris, France, July 05-08, 2008. Accepted as Oral Presentation View
  110. Bradley CS. Bowel Symptoms in Women One Year after Sacrocolpopexy. . ICI, Paris, France, July 05-08, 2008. Accepted as Oral Presentation View
  111. Nygaard I. Changes in Physical Activity afer Sacrocolpopexy for Advanced Pelvic Organ Prolapse. ICI, Paris, France, July 05-08, 2008. Accepted as Oral Presentation View
  112. Visco AG. The Role of Pre-Operative Urodynamic Testing in Stress Continent Women Undergoing Sacrocolpopexy: The Colpopexy and Urinary Reduction Efforts (CARE) Randomized Surgical Trial. ICI, Paris, France, July 05-08, 2008. Accepted as Oral Presentation View
  113. Handa VL. Racial differences in the bony pelvis of primiparous women. ICI, Paris, France, July 05-08, 2008. Accepted as Oral Presentation View
  114. Lockhart ME. Evaluation of Dynamic MIR Pelvic Floor Measurement Variability in a Multicenter Trial. ICI, Paris, France, July 05-08, 2008. Accepted as Oral Presentation View
  115. Lockhart ME. Evaluation of Dynamic MIR Pelvic Floor Measurement Variability in a Multicenter Trial. ICI, Paris, France, July 05-08, 2008. Accepted as Oral Presentation View
  116. Fitzgerald MP. Pelvic support, pelvic symptoms and patient satisfaction after colpocleisis. ICI, Paris, France, July 05-08, 2008. Accepted as Oral Presentation View
  117. Whitehead WE. National Health and Nutrition Examination Survey (NHANES): Association of Usual Stool Consistency and Frequency with Fecal Incontinence. Digestive Disease Week , San Diego, CA, May 17-22, 2008. Accepted as Oral Presentation View
  118. Whitehead WE. National Health and Nutrition Examination Survey (NHANES) of Fecal Incontinence: Characteristics of Incontinent Stools. Digestive Disease Week , , May 17-22, 2008. Accepted as Oral Presentation View
  119. Whitehead WE. National Health and Nutrition Examination Survey (NHANES) of Fecal Incontinence: Prevalence by Sex, Age, Race, Marital Status, Education, and Income. Digestive Disease Week , San Diego, CA, May 17-22, 2008. Accepted as Oral Presentation View
  120. Whitehead WE. National Health and Nutrition Examination Survey (NHANES) of Stool Frequency and Consistency in U.S. Adults. Digestive Disease Week , San Diego, CA, May 17-22, 2008. Accepted as Oral Presentation View
  121. Fitzgerald MP, Goode PS. Enhancing participation of older women in surgical trials. ACOG, New Orleans, LA, May 03-07, 2008. Accepted as Oral Presentation View
  122. Cundiff G. Polytetrafluoroethylene Mesh , Concurrent Hysterectomy and Smoking are Risk Factors for Mesh/Suture Erosions Following Sacrocolpopexy. . Society of Gynecologic Surgeons, Savannah, April 14-16, 2008. Accepted as Oral Presentation View
  123. Wren PA. Relationship between optimism and patient-centered outcomes before and after sacrocolpopexy for pelvic organ prolapse. Society of Gynecologic Surgeons, Savannah, April 14-16, 2008. Accepted as Oral Presentation View
  124. Handa VL, Lockhart ME. Racial differences in the bony pelvis and pelvic soft tissues of primiparous women. Radiological Society of North America, Chicago, IL, November 01, 2007. Accepted as Oral Presentation View
  125. Lockhart ME. Reproducibility of Dynamic MRI Pelvic Measures: A Multi-Site Study. . Radiological Society of North America, Chicago, IL, November 01, 2007. Accepted as Oral Presentation View
  126. Brubaker L. The colpopexy and urinary reduction efforts (CARE) trial: Two year outcomes. . American Urogynecologic Society, Hollywood, FL, September 01, 2007. Accepted as Oral Presentation View
  127. Goode P. Change in physical activity one year after sacrocolpopexy. American Urogynecologic Society, Hollywood, FL, September 01, 2007. Accepted as Oral Presentation View
  128. Brubaker L. Refractory urge urinary incontinence and Botulinum A toxin injection (RUBI) trial. American Urogynecologic Society, Hollywood, FL, September 01, 2007. Accepted as Oral Presentation View
  129. Brubaker L. The colpopexy and urinary reduction efforts (CARE) trial: Two year outcomes. . International Continence Society, Rotterdam, August 01, 2007. Accepted as Oral Presentation View
  130. Brubaker L. Refractory urge urinary incontinence and Botulinum A toxin injection (RUBI) trial. International Continence Society, Rotterdam, August 01, 2007. Accepted as Oral Presentation View
  131. Mueller ER. Does Urethral Function Affect Urodynamic Voiding Parameters in Women with Prolapse? . American Urological Association, Anaheim, CA, May 01, 2007. Accepted as Oral Presentation View
  132. Mueller ER. The Correlation of Voiding Variables Between Non-instrumented Uroflometery and Pressure-folw Studies in Women with Pelvic Organ Prolapse. American Urogynecologic Society, Anaheim, CA, May 01, 2007. Accepted as Oral Presentation View
  133. Handa VL, Zyczynski H. The impact of fecal and urinary incontinence on quality of life 6 months after childbirth. Society of Gynecologic Surgeons, Orlando, FL, April 01, 2007. Accepted as Oral Presentation View
  134. Richter HE. Bladder Symptoms One Year After Abdominal Sacrocolpopexy with and without Burch Colposuspension in Women without Preoperative Stress Incontinence Symptoms. Society of Gynecologic Surgeons, Orlando FL, April 01, 2007. Accepted as Oral Presentation View
  135. Bradley CS. Bowel Symptoms in Women One Year after Sacrocolpopexy. Society of Gynecologic Surgeons, Orlando, FL, April 01, 2007. Accepted as Oral Presentation View
  136. Handa VL. Sexual Function Before and After Sacrocolpopexy for Advanced Prolapse. . Society of Gynecologic Surgeons, Orlando, FL, April 01, 2007. Accepted as Oral Presentation View
  137. Burgio K. Risk Factors for Fecal and Urinary Incontinence after Childbirth: The Childbirth and Pelvic Symptoms Study. Maternal-Fetal Medicine, San Francisco, CA, February 01, 2007. Accepted as Oral Presentation View
  138. Mueller ER. Impact of stress urinary incontinence voiding function in women with prolapse. . Society of Urodynamics and Female Urology, San Diego, CA, February 01, 2007. Accepted as Oral Presentation View
  139. Fine P. Rates of Teaching and Practice of Pelvic Floor Muscle Exercises in Primiparous Women Before and After Delivery. American Urogynecologic Society, Palm Springs, CA, October 01, 2006. Accepted as Oral Presentation View
  140. Richter H. Irritative and Obstructive Bladder Symptoms in Women with Prolapse, Comparing Those WIth and Without Concomitant Stress Incontinence Symptoms. American Urogynecologic Society, Palm Springs, CA, October 01, 2006. Accepted as Oral Presentation View
  141. Whitehead WE. Postoperative Gastrointestinal Complications After Abdominal Sacrocolpopexy for Advanced Pelvic Organ Prolapse. American Urogynecologic Society, Palm Springs, CA, October 01, 2006. Accepted as Oral Presentation View
  142. Whitehead WE. Fecal Incontinence Following Obstetrical Anal Sphincter Laceration is Associated with Frequent Loose Stools. American Motility Society, Boston, MA, September 01, 2006. Accepted as Oral Presentation View
  143. Richter H. The Effect of Age on Short-term Outcomes After Abdominal Surgery for Severe Pelvic Organ Prolapse. American Geriatric Society (AGS), Chicago, IL, May 01, 2006. Accepted as Oral Presentation View
  144. Borello-France D, Burgio K, Richter H. Fecal and Urinary Incontinence after Childbirth: The Childbirth and Pelvic Symptoms (CAPS) Study. American College of Obstetrics and Gynecology, Washington, DC, May 01, 2006. Accepted as Oral Presentation View
  145. Visco AG. The Role of Pre-Operative Urodynamic testing in Stress Continent Women Undergoing Sacrocolpopexy: The Colpopexy and Urinary Reduction Efforts (CARE) Randomized Surgical Trial. Society of Gynecologic Surgeons, Tucson, AZ, April 01, 2006. Accepted as Oral Presentation View
  146. Richter H. Ultrasound and Magnetic Resonance Imaging of the Anal Sphincter After First Delivery: Relationship to Fecal Incontinence Symptoms. Society for Gynecologic Investigation (SGI), Toronto, Canada, March 01, 2006. Accepted as Oral Presentation View
  147. Wren PA. Development of the Adaptations Index for women with pelvic floor disorders: The value of the patient’s voice. American Public Health Association, Philadelphia, PA, December 01, 2005. Accepted as Oral Presentation View
  148. Brubaker L. Delivery-associated Anal Sphincter Lacerations: Is this Event Coded Accurately?. Central Association of Obstetricians and Gynecologists, Scottsdale, AZ, October 01, 2005. Accepted as Oral Presentation View
  149. Brubaker L. Burch Colposuspension at the Time of Sacrocolpopexy in Stress Continent Women Reduces Bothersome Stress Urinary Symptoms: The CARE Randomized Trial. Society of Pelvic Surgeons, Lyons, France, October 01, 2005. Accepted as Oral Presentation View
  150. Borello-France D. Pelvic Floor Muscle Function in Women with Prolapse. American Urogynecologic Society, Atlanta, GA, September 01, 2005. Accepted as Oral Presentation View
  151. Zyczynski HM. Sexual Function in Women Planning Sacrocolpopexy. American Urogynecologic Society, Atlanta, GA, September 01, 2005. Accepted as Oral Presentation View
  152. Brubaker L. Burch Colposuspension at the Time of Sacrocolpopexy in Stress Continent Women Reduces Bothersome Stress Urinary Symptoms: The CARE Randomized Trial. American Urogynecologic Society, Atlanta, GA, September 01, 2005. Accepted as Oral Presentation View
  153. Handa V. Preoperative patterns of physical activity in women planning sacrocolpopexy for pelvic organ prolapse. International Continence Society, Montreal, Canada, August 01, 2005. Accepted as Oral Presentation View
  154. Fitzgerald MP. Relationship between stage of pelvic organ prolapse and symptoms of pelvic dysfunction. International Continence Society, Montreal, Canada, August 01, 2005. Accepted as Oral Presentation View
  155. Zyczynski HM. Sexual Function in Women Planning Sacrocolpopexy. International Continence Society, Montreal, Canada, August 01, 2005. Accepted as Oral Presentation View
  156. Fitzgerald MP, Pelvic Floor Disorders Network. Risk factors for anal sphincter laceration in primiparous women. International Continence Society, Montreal, Canada, August 01, 2005. Accepted as Oral Presentation View
  157. Fitzgerald MP. Relationship between stage of pelvic organ prolapse and symptoms of pelvic dysfunction. Society of Gynecologic Surgeons, Rancho Mirage, CA, April 01, 2005. Accepted as Oral Presentation View
  158. Fitzgerald MP, Pelvic Floor Disorders Network. Risk factors for anal sphincter laceration in primiparous women. . Society of Gynecologic Surgeons, Rancho Mirage, CA, April 01, 2005. Accepted as Oral Presentation View
  159. Wren PA, Janz NK, Brubaker L, Weber AM, LaPorte FB, Wei JT. Reconstructive Pelvic Surgery: The Quality of Life One Year Later. Central Association of Obstetricians and Gynecologists, , October 01, 2004. Accepted as Oral Presentation View
  160. Visco A, Pelvic Floor Disorders Network. Comparison of measurements obtained with microtip and external water pressure transducers. International Continence Society/International Urogynecological Association, Paris, France, August 01, 2004. Accepted as Oral Presentation View
  161. Bradley CS. Bowel symptoms in women planning surgery for pelvic organ prolapse. Society of Gynecologic Surgeons, Tucson, AZ, April 01, 2004. Accepted as Oral Presentation View
  162. Kwon S, Pelvic Floor Disorders Network. Validity and Reliability of Fecal Incontinence Severity and Quality of Life Scales Administered by Telephone. . American Urogynecologic Society, Hollywood, FL, September 01, 2003. Accepted as Oral Presentation View
  163. Brubaker L, Pelvic Floor Disorders Network. Effects of examination technique modifications on pelvic organ prolapse quantification (POP-Q) results. . International Urogynecological Association, Prague, Czech Republic, August 01, 2002. Accepted as Oral Presentation View
  164. Brubaker L, Pelvic Floor Disorders Network. Colpopexy and urinary reduction efforts (CARE), a randomized trial of abdominal sacrocolpopexy with/without Burch colposuspension. International Urogynecological Association, Prague, Czech Republic, August 01, 2002. Accepted as Oral Presentation View
  165. Richter HE, Nager CW, Whitworth R, Burgio KL, Schaffer J, Norton P, Weidner A, Jelovsek JE, Zyczynski H, Meikle S, Spino C, Gantz MG, Graziano S, Brubaker L, Pelvic Floor Disorders Network. Incidence and Predictors of Anal Incontinence after Obstetric Anal Sphincter Injury in Primiparous Women . International Continence Society, , Accepted as Poster View

 
For more information about the Pelvic Floor Disorders Network, please contact a clinical site in your area.